High-performance liquid chromatographic method for the determination of fenofibric acid and reduced fenofibric acid in human blood, plasma and urine

Yakugaku Zasshi

Volumn 118, Issue 10, 1998, Pages 447-455

  Abe, Sadahiro ^a   Ono, Kaoru ^a   Mogi, Masayuki ^a   Hayashi, Tokishi ^a  

^a Grelan Pharmaceutical Co Ltd   (Japan)

Author keywords

Fenofibric acid; HPLC; Quantitative determination; Reduced fenofibric acid

Indexed keywords

ACETIC ACID ETHYL ESTER; BETA GLUCURONIDASE; FENOFIBRIC ACID; FIBRIC ACID DERIVATIVE; FLURBIPROFEN; HEXANE; HYDROCHLORIC ACID; METHANOL; WATER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; ORAL DRUG ADMINISTRATION; REPRODUCIBILITY;

EID: 0031766228     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi1947.118.10_447     Document Type: Article

References (5)

1. Weil A., Caldwell J., Strolin-Benedetti M., Drug Metab. Dispos., 18, 115-120 (1989).
2. Desager J. P., J. Chromatogr., 145, 160-164 (1978).
3. Luley C., Kegel H., Jakobs C., J. Chromatogr., 224, 500-502 (1981).
4. Caturla M. C., Albaiges J., J. Chromatogr., 227, 219-222 (1982).
5. Cotta Ramusno A., Carozzi A., J. Chromatogr., 383, 419-424 (1986).